Decrease in hematocrit after coronary stent placement and dextran therapy

The American Journal of Cardiology
W H HaughtJ L Mehta

Abstract

In summary, dextran 40, when given after coronary stent placement, results in a marked decrease in hematocrit within 24 hours. Hematocrit often returns to near baseline levels within 48 hours of stopping dextran. This phenomenon most likely reflects dextran-related hemodilution. This hemodilutional decrease in hematocrit is often misinterpreted as acute blood loss and may result in blood transfusion in patients with low baseline hematocrit. However, far less aggressive anticoagulation regimens, which do not include dextran, are under investigation in patients undergoing coronary stent placement.

Citations

Oct 13, 2007·Biomacromolecules·Hironobu TakahashiDavid W Grainger
Jul 1, 1997·The American Journal of Cardiology·W JauchW H Matthai
Jul 6, 2010·The American Journal of Cardiology·Olivier F BertrandLouis Roy
Dec 14, 2004·Vascular and Endovascular Surgery·Farshad AbirBauer E Sumpio
Aug 23, 2012·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Chi-Te WangPo-Wen Cheng
Sep 10, 2002·Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology·Shuo-Tzung KuoYi-Ho Young
Sep 21, 2021·European Journal of Clinical Investigation·Gjin NdrepepaAdnan Kastrati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.